Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.
about
Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosaInterplay in the selection of fluoroquinolone resistance and bacterial fitnessDifferential gene expression by RamA in ciprofloxacin-resistant Salmonella TyphimuriumFitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genesThe PK-PD Relationship and Resistance Development of Danofloxacin against Mycoplasma gallisepticum in An In Vivo Infection Model.Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolatesDetection of mcr-1-Carrying Escherichia coli Causing Bloodstream Infection in a New York City Hospital: Avian Origins, Human Concerns?The role of host factors and bacterial virulence genes in the development of pyelonephritis caused by Escherichia coli in renal transplant recipients.Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli.Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.Cost of adaptation and fitness effects of beneficial mutations in Pseudomonas fluorescens.Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure.Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance.Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistanceAntibiotics and the gut microbiota.Genomic variation landscape of the human gut microbiome.Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa.Genomewide screen for modulators of evolvability under toxic antibiotic exposure.gyrA mutations in ciprofloxacin-resistant Bartonella bacilliformis strains obtained in vitroSelective advantage of resistant strains at trace levels of antibiotics: a simple and ultrasensitive color test for detection of antibiotics and genotoxic agents.Chromosomal and plasmid-mediated fluoroquinolone resistance mechanisms among broad-spectrum-cephalosporin-resistant Escherichia coli isolates recovered from companion animals in the USAAlarmingly High Segregation Frequencies of Quinolone Resistance Alleles within Human and Animal Microbiomes Are Not Explained by Direct Clinical Antibiotic ExposureEffects of a Mutation in the gyrA Gene on the Virulence of Uropathogenic Escherichia coli.A fluoroquinolone resistance associated mutation in gyrA Affects DNA supercoiling in Campylobacter jejuniSupercoiling Effects on Short-Range DNA Looping in E. coli.Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli.Molecular characterization of fluoroquinolone-resistant Aeromonas spp. isolated from imported shrimp.Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistanceFluoroquinolone-resistant mutants of Burkholderia cepaciaDetermination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coliGenetic mechanisms of antimicrobial resistance identified in Salmonella enterica, Escherichia coli, and Enteroccocus spp. isolated from U.S. food animalsCharacterization of multiple-antimicrobial-resistant Escherichia coli isolates from diseased chickens and swine in China.Development and validation of a diagnostic DNA microarray to detect quinolone-resistant Escherichia coli among clinical isolates.Recent Outbreaks of Shigellosis in California Caused by Two Distinct Populations of Shigella sonnei with either Increased Virulence or Fluoroquinolone Resistance.Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants Selected with a fluoroquinolone.Differential phenotypic and genotypic characteristics of qnrS1-harboring plasmids carried by hospital and community commensal enterobacteria.Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance.Role of topoisomerase mutations and efflux in fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants.Resistance Mutations in gyrA and parC are Common in Escherichia Communities of both Fluoroquinolone-Polluted and Uncontaminated Aquatic EnvironmentsQuantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance.
P2860
Q21144908-6265F4EB-7680-408B-9A6B-3E1FF34A42A6Q28475870-AC4C65F3-96E4-461E-BF13-510BF99E5F22Q28479202-593E3091-7B53-46A7-B73C-811CBD26B7D5Q33559090-49A0C356-3541-4008-8B2F-B888DCF81D3CQ33736566-0A6BE143-2C51-48C7-B390-8217D2E4D558Q33836603-2BF65BF7-28A9-4621-91F8-5B9FC57E7184Q33901460-ECDDB1C8-9EBE-4E95-9332-751B19CB6950Q33944841-11D638F0-2443-4BDC-A3D8-89EF415C979DQ33979064-2EEECF78-81CC-4AEE-AB62-69535E89A9CCQ33982113-55EBBCF1-8BB2-468C-BEB7-413046016C47Q34003200-105EC190-B4A8-4E11-A204-C92FE2F8BFEAQ34019104-18EBEA9F-C05D-432E-AEFE-157808C42865Q34077142-30BE3CA5-7C52-40C3-944D-91DEE46D94C2Q34102811-A6E15D74-D404-44A0-B91F-1548AB6127C4Q34311624-DDC1ED96-379F-4CA3-9856-C72A54957F27Q34316353-2CA0AA28-2DAE-4557-8C8A-EDD1B157B61CQ34384649-14CB206D-47D8-495B-95E0-52C810544D64Q34719336-A7D672DB-04A5-41ED-B6E1-BC4BC30D040DQ34720856-33A8381D-C907-4A01-90AD-797E88C93A63Q34737391-DB89E338-2FFC-497B-8F57-C582CB3FB70CQ35555287-5E5C7510-5651-468A-B26A-4B36DA6F6DB9Q35644230-A3BD97E3-D5E5-4C4E-8B02-3CC2C33D272BQ35860017-B2BE4960-DD47-493D-ACD6-FFCB5DB78B09Q36159080-E1C0C65C-DE01-46A6-8EB5-AB5798ED2481Q36175103-C908805A-A52F-434B-9748-DB6D48E6976DQ36295431-02CF39FD-5623-4EDA-9371-581DC5649E53Q36362417-5BC7DD68-2731-4A4D-8377-3CD2B739AA17Q36452433-F6FF3301-A318-4242-96DE-4D964DBB1090Q36482751-E9BCA71F-4E18-4B94-84B9-6197CC14043FQ36845531-5F3299F7-726D-4DB9-BCD7-439D9FC24A6AQ36868647-5DA1E352-D638-453C-A6E9-82D24B88BE87Q37157491-119B8675-B382-471C-B4A0-A943ED9809DAQ37511160-3DBF2946-4F22-467C-B6E3-807E938FF19DQ38376613-82B05C3E-FC51-4D56-A5E8-A1BC65524D8EQ39477158-4A6B2D24-6EB2-4688-B3D9-6D8657A21B3BQ39560238-87E3CB9B-D1D4-4E7B-8B71-5881C34D126CQ39651132-7BDAFBF3-1084-4AB6-B8E5-4CF117AB660FQ40705759-59E8023D-D092-426E-9478-A761CAEB18ABQ40860093-9ADDE190-3BA1-40E4-A373-622C401605F0Q41454301-2B0B5122-BAB7-40D0-B1A6-8F5A50C8AC6C
P2860
Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Impact of gyrA and parC mutati ...... ng degree of Escherichia coli.
@ast
Impact of gyrA and parC mutati ...... ng degree of Escherichia coli.
@en
type
label
Impact of gyrA and parC mutati ...... ng degree of Escherichia coli.
@ast
Impact of gyrA and parC mutati ...... ng degree of Escherichia coli.
@en
prefLabel
Impact of gyrA and parC mutati ...... ng degree of Escherichia coli.
@ast
Impact of gyrA and parC mutati ...... ng degree of Escherichia coli.
@en
P2093
P2860
P356
P1476
Impact of gyrA and parC mutati ...... ing degree of Escherichia coli
@en
P2093
P2860
P304
P356
10.1128/AAC.43.4.868
P407
P577
1999-04-01T00:00:00Z